Financhill
Back

Consumer Portfolio Services Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
34

CPSS
Consumer Portfolio Services

Last Price:
$9.20
Seasonality Move:
5.52%
Buy
54

DRUG
Bright Minds Biosciences

Last Price:
$35.96
Seasonality Move:
-28.52%
Sell
34
Consumer Portfolio Services (CPSS) is a Sell

Is Consumer Portfolio Services a Buy, Sell or Hold?

  • The current Consumer Portfolio Services [CPSS] share price is $9.27. The Score for CPSS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CPSS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Bright Minds Biosciences (DRUG) is a Buy

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $36.25. The Score for DRUG is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CPSS Stock Price Chart

What is Consumer Portfolio Services's stock price today?

  • The Consumer Portfolio Services share price today is $9.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPSS is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $36.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

CPSS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 32.06 Sell
Chaikin Money Flow: 23362 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.66 - 11.34) Sell
Bollinger Bands (100): (9.92 - 11.32) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 50.3 Buy
Chaikin Money Flow: 47724 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CPSS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.47 Sell
20-day SMA: 10.29 Sell
50-day SMA: 10.88 Sell
200-day SMA: 9.87 Sell
8-day EMA: 9.53 Sell
20-day EMA: 10.1 Sell
50-day EMA: 10.55 Sell
200-day EMA: 10.09 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.16 Buy
20-day SMA: 37.2 Sell
50-day SMA: 37.07 Sell
200-day SMA: 20.27 Buy
8-day EMA: 35.28 Buy
20-day EMA: 36.12 Buy
50-day EMA: 36.52 Sell
200-day EMA: 24.96 Buy

Consumer Portfolio Services Earnings Growth & CPSS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $1.08 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.85 per share, and a decrease next year of $2.17 per share.

Consumer Portfolio Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):